108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD

The NASH space has seen some setbacks in the last couple years, but a few players continue to make nice progress on their clinical trials. Madrigal Pharma announced positive topline data in their MAESTRO-NAFLD trial, which is an encouraging sign for their upcoming readout in NASH in Q3-2022. I discuss other players in the space including: ETNB, AKRO, VKTX, ICPT, IVA and NVO. Checkpoint Therapeutics announces positive topline data from their trial of Cosibelimab in metastatic cutaneous squamous cell carcinoma. I talk to about what we can look forward to in 2022 for this company as well. Thanks to InfoPathways for being a sponsor of the show! Check them out for all your biotech IT needs at infopathways.com or call 410-751-9929. Help out the show (or join the discord) by becoming a patron at: Follow me on twitter @matthewlepoire Send me an email matthewlepoire@gmail.com Disclaimer: All opinions expressed by Matt (or his guests) in this podcast are solely his (their) opinions. You should not treat any opinion expressed by Matt in this podcast as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Matt's opinions are based upon information he considers reliable, but Matt (nor his guests) cannot warrant its completeness or accuracy, and it should not be relied upon as such. Matt (nor his guests) is/are not under any obligation to update or correct any information provided in this podcast. Past performance is not indicative of future results. Matt (nor his guests) does/do not guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed in this podcast.

You can listen to 108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD online on Radio and Podcast. Open the player on this page to stream the available audio.

108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD is an episode from Breaking Biotech by Matthew Lepoire.

This episode is 00:37:28 long.

This episode was published on Feb 7, 2022.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Breaking Biotech when more episodes are available from the podcast feed.